COMMON VARIABLE IMMUNODEFICIENCY
Clinical trials for COMMON VARIABLE IMMUNODEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new COMMON VARIABLE IMMUNODEFICIENCY trials appear
Sign up with your email to follow new studies for COMMON VARIABLE IMMUNODEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New IVIG aims to slash infection risk for immune-deficient patients
Disease control Not yet recruitingThis study tests a new medicine called Boya IVIG in 50 people with primary immunodeficiency (CVID or XLA), a condition where the body can't fight infections well. Participants get the drug every 21 or 28 days for a year to see if it keeps serious bacterial infections below one pe…
Matched conditions: COMMON VARIABLE IMMUNODEFICIENCY
Phase: PHASE3 • Sponsor: Azidus Brasil • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Immune cell clues: could t-cells explain hidden CVID complications?
Knowledge-focused Not yet recruitingThis study looks at why some people with Common Variable Immunodeficiency (CVID) develop complications not caused by infections. Researchers will test whether a type of immune cell called peripheral helper T-cells (Tph) helps faulty B-cells produce antibodies that lead to these c…
Matched conditions: COMMON VARIABLE IMMUNODEFICIENCY
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC